- RE: Metastasis of Gallbladder Adenocarcinoma to Bauhin's Valve: An Extremely Rare Cause of Intestinal Obstruction
-
Virgilio E, Giaccaglia V, Balducci G
- KMID: 1734953
- Korean J Radiol.
- 2014 Oct;15(5):655-656.
- doi: 10.3348/kjr.2014.15.5.655
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Monoclonal Gammopathy in Extranodal Marginal Zone B-cell Lymphoma of the Small Intestine
-
Kim DY, Kim YS, Huh HJ, Choi JS, Yeo JS, Kwak BS, Chae SL
- KMID: 1096655
- Korean J Lab Med.
- 2011 Jan;31(1):18-21.
- doi: 10.3343/kjlm.2011.31.1.18
Monoclonal gammopathy occurs in one-third of the patients with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma). However, monoclonal gammopathy has been rarely reported in Korea. Paraprotenemia accompanying MALT lymphoma is strongly... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of vascular endothelial growth factor inhibition on simple renal cysts in patients receiving bevacizumab-based chemotherapy
-
Grenader T, Shavit L
- KMID: 2359870
- Korean J Urol.
- 2015 Dec;56(12):791-795.
- doi: 10.4111/kju.2015.56.12.791
PURPOSE: Although angiogenesis has been implicated in the promotion of renal cyst growth in autosomal dominant polycystic kidney disease, no studies have investigated the role of angiogenesis in the growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea
-
Kim SJ, Cheong JW, Min YH, Choi YJ, Lee DG, Lee JH, Yang DH, Lee SM, Kim SH, Kim YS, Kwak JY, Park J, Kim JY, Kim HG, Kim BS, Ryoo HM, Jang JH, Kim MK, Kang HJ, Cho IS, Mun YC, Jo DY, Kim HY, Park BB, Kim JS
- KMID: 1796916
- J Korean Med Sci.
- 2014 Jan;29(1):61-68.
- doi: 10.3346/jkms.2014.29.1.61
We assessed the success rate of empirical antifungal therapy with itraconazole and evaluated risk factors for predicting the failure of empirical antifungal therapy. A multicenter, prospective, observational study was performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
-
Han DH, Joo DJ, Kim MS, Choi GH, Choi JS, Park YN, Seong J, Han KH, Kim SI
- KMID: 2374176
- Yonsei Med J.
- 2016 Sep;57(5):1276-1281.
- doi: 10.3349/ymj.2016.57.5.1276
Locally advanced hepatocellular carcinoma (HCC) with portal vein thrombosis carries a 1-year survival rate -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B and C Virus Infection and Liver Dysfunction in Patients Receiving Chemotherapy
-
Kwon CI, Lee JH, Choi KH, Ko KH, Hong SP, Hwang SG, Park PW, Oh D, Rim KS, Kim S
- KMID: 782802
- Korean J Gastroenterol.
- 2006 Dec;48(6):408-414.
BACKGROUND/AIMS: Liver dysfunction and reactivation of hepatitis virus are well-described complications in cancer patients who receive cytotoxic chemotherapy and may result in varying degrees of liver damage. However, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea
-
Baek SH, Kim H, Lee J, Kim DK, Oh KH, Kim YS, Han JS, Kim TM, Lee SH, Joo KW
- KMID: 1792011
- Korean J Intern Med.
- 2014 Jan;29(1):40-48.
- doi: 10.3904/kjim.2014.29.1.40
BACKGROUND/AIMS: Sunitinib is an oral multitargeted tyrosine kinase inhibitor used mainly for the treatment of metastatic renal cell carcinoma. The renal adverse effects (RAEs) of sunitinib have not been investigated.... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
-
Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH
- KMID: 2363034
- Clin Mol Hepatol.
- 2016 Mar;22(1):160-167.
- doi: 10.3350/cmh.2016.22.1.160
BACKGROUND/AIMS: Treating hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) remains controversial. We compared the outcomes of hepatic resection (HR), transarterial chemoembolization (TACE), and sorafenib therapy as treatments for... -
- CITED
-
- Close
- SHARE
-
- Close
